Simpler Grants.gov #PAR-25-183

NIH Grant for Early Stage Testing of Novel Mental Health Interventions

This opportunity from the National Institutes of Health (NIH), specifically the National Institute of Mental Health (NIMH), seeks grant applications for early stage testing of pharmacologic or device-based interventions for mental disorders. - Government Buyer: - National Institutes of Health (NIH), National Institute of Mental Health (NIMH) - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or vendors are named - Products/Services Requested: - Early stage testing of pharmacologic or neuromodulatory device-based interventions - Focus on interventions with novel mechanisms of action - Protocols must test the presumed mechanism of action and provide data on target modulation and neurophysiological, clinical, or behavioral effects - Unique or Notable Requirements: - Supports experimental therapeutics approaches - Evaluates both clinical effects and underlying mechanisms - Open to a wide range of applicants: nonprofits, government, businesses, and educational institutions - No cost sharing or matching required - No specific products, part numbers, or purchase quantities listed - Funding instrument is a discretionary grant - Place of performance and contracting office: National Institutes of Health

Description

This funding opportunity from the National Institutes of Health supports early stage testing of pharmacologic or device-based interventions for mental disorders. The focus is on interventions with novel mechanisms of action, using protocol designs that test the presumed mechanism of action to provide meaningful information on target modulation effects. The goal is to evaluate both the clinical effect and underlying mechanisms of the interventions. Eligible applicants include a wide range of nonprofit, government, business, and educational entities.

View original listing